DNA Damage/DNA Repair
Research Areas
- MTH1(4)
- PARP(115)
- ATM/ATR(33)
- DNA Alkylating(23)
- DNA Ligases(3)
- DNA Methyltransferase(29)
- DNA-PK(31)
- HDAC(157)
- Nucleoside Antimetabolite/Analogue(200)
- Telomerase(16)
- Topoisomerase(210)
- tankyrase(5)
- Antifolate(36)
- CDK(343)
- Checkpoint Kinase (Chk)(39)
- CRISPR/Cas9(9)
- Deubiquitinase(86)
- DNA Alkylator/Crosslinker(95)
- DNA/RNA Synthesis(613)
- Eukaryotic Initiation Factor (eIF)(34)
- IRE1(25)
- LIM Kinase (LIMK)(12)
- TOPK(6)
- Casein Kinase(62)
- DNA Intercalating Agents(8)
- DNA/RNA Oxidative Damage(13)
- Poly(ADP-ribose) Glycohydrolase (PARG)(6)
- Early 2 Factor (E2F)(2)
- Zinc Finger Protein(1)
Products Related to DNA Damage/DNA Repair(2120)
- GC79113Casein Kinase II Substrate acetatePurity: >99.50%
Casein Kinase II Substrate acetate is a casein kinase II ( CK2 ) peptide substrate that can be selectively phosphorylated by CK2 [1] .
- GC79114CCK1-specific peptide substrate acetatePurity: >98.00%
CCK1-specific peptide substrate acetate is a biological active peptide.
- GC79150NV914CAS: 2341941-41-9Purity: >98.50%
NV914 is an inhibitor of FTSJ1 (tryptophan tRNA-specific 2'-O-methyltransferase) that inhibits the methyltransferase activity of FTSJ1, induces translational readthrough of premature termination codons, and enables genes carrying nonsense mutations to synthesize full-length proteins.
- GC79167METTL1-WDR4-IN-1 TFAPurity: >99.50%
METTL1-WDR4-IN-1 (Compound 1) TFA is a selective competitive inhibitor of the methyltransferase complex METTL1-WDR4 ( IC 50 =144 μM).
- GC79176ARUK2010489Purity: >96.50%
ARUK2010489 (Compound 23) is a potent, selective and brain-penetrant NUAK1 inhibitor with a pIC 50 of 8.7.
- GC79370PD-L1/HDAC6-IN-1 TFAPurity: >99.50%
PD-L1/HDAC6-IN-1 TFA is an orally active dual inhibitor of PD-L1 and HDAC6, with IC 50 values of 26.8 nM and 78 nM, respectively.
- GC79488QBS10072S dihydrochlorideCAS: 1802735-31-4Purity: >98.00%
QBS10072S dihydrochloride is a LAT1 -selective substrate with blood-brain barrier permeability that inhibits tumor growth.
- GC79577PFKFB4-IN-1CAS: 2664831-55-2Purity: >99.50%
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels.
- GC79584UDP-GlucosamineCAS: 17479-04-8Purity: >98.00%
UDP-Glucosamine is a sugar nucleotide analog, glycosyl donor, and metabolite of D-galactosamine.
- GC79816CryptolepineCAS: 480-26-2Purity: >98.00%
Cryptolepine is an orally active multi-potent alkaloid with anti-cancer, anti-bacterial, anti-viral, anti-malarial, anti-inflammatory, anti-hyperglycemic, relieve pain and other properties.
- GC79867Prexasertib-d 4Purity: >98.00%
Prexasertib -d 4 (LY2606368-d 4 ) is the deuterium labeled Prexasertib.
- GC79871CHNQD-00824CAS: 2222643-74-3Purity: >98.00%
CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect.
- GC79989Irinotecan- 13 C 6CAS: 718613-65-1Purity: >98.00%
Irinotecan - 13 C 6 ((+)-Irinotecan- 13 C 6 ) is the 13 C-labeled Irinotecan.
- GC79990Gemcitabine- 13 C, 15 N 2CAS: 1233921-74-8Purity: >99.00%
antimetabolite and an antineoplastic agent.
- GC79991Im-m7GDP sodiumCAS: 240137-51-3Purity: >89.00%
Im-m7GDP sodium is a capping reagent and also the P-imidazolide of N7-methylguanosine 5'-diphosphate.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79112 | PF-670462 | 950980-98-0 | >99.00% | |
PF-670462 is a selective CKI ε/δ inhibitor. | ||||
| GC79113 | Casein Kinase II Substrate acetate | - | >99.50% | |
Casein Kinase II Substrate acetate is a casein kinase II ( CK2 ) peptide substrate that can be selectively phosphorylated by CK2 [1] . | ||||
| GC79114 | CCK1-specific peptide substrate acetate | - | >98.00% | |
CCK1-specific peptide substrate acetate is a biological active peptide. | ||||
| GC79121 | XL495 | 3040320-93-9 | >98.00% | |
XL495 is an potent, selective and orally active PKMYT1 inhibitor. | ||||
| GC79144 | MC3817 free base | - | >98.00% | |
MC3817 free base is a selective DNMT1 inhibitor. | ||||
| GC79145 | MC3817 | - | >99.50% | |
MC3817 is a selective DNMT1 inhibitor. | ||||
| GC79150 | NV914 | 2341941-41-9 | >98.50% | |
NV914 is an inhibitor of FTSJ1 (tryptophan tRNA-specific 2'-O-methyltransferase) that inhibits the methyltransferase activity of FTSJ1, induces translational readthrough of premature termination codons, and enables genes carrying nonsense mutations to synthesize full-length proteins. | ||||
| GC79167 | METTL1-WDR4-IN-1 TFA | - | >99.50% | |
METTL1-WDR4-IN-1 (Compound 1) TFA is a selective competitive inhibitor of the methyltransferase complex METTL1-WDR4 ( IC 50 =144 μM). | ||||
| GC79176 | ARUK2010489 | - | >96.50% | |
ARUK2010489 (Compound 23) is a potent, selective and brain-penetrant NUAK1 inhibitor with a pIC 50 of 8.7. | ||||
| GC79354 | YL0441 | - | >98.50% | |
YL0441 is an inhibitor of ΔFOSB/JUND heterodimers and ΔFOSB homomultimers, with IC 50 values of 13.7 μM and 12.3 μM, respectively. | ||||
| GC79370 | PD-L1/HDAC6-IN-1 TFA | - | >99.50% | |
PD-L1/HDAC6-IN-1 TFA is an orally active dual inhibitor of PD-L1 and HDAC6, with IC 50 values of 26.8 nM and 78 nM, respectively. | ||||
| GC79451 | JP-11646 | 1902983-63-4 | >98.50% | |
JP-11646 is a pan-PIM inhibitor with increased potency against PIM2 ( IC 50 = 0.5 nM). | ||||
| GC79476 | ETC-501 | 3094990-88-9 | >97.00% | |
ETC-501 is a blood-brain barrier-permeable, orally active, and selective MNK1 / MNK2 inhibitor, with an IC 50 of 0.033 μM against MNK1 and 0.111 μM against MNK2. | ||||
| GC79488 | QBS10072S dihydrochloride | 1802735-31-4 | >98.00% | |
QBS10072S dihydrochloride is a LAT1 -selective substrate with blood-brain barrier permeability that inhibits tumor growth. | ||||
| GC79577 | PFKFB4-IN-1 | 2664831-55-2 | >99.50% | |
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels. | ||||
| GC79584 | UDP-Glucosamine | 17479-04-8 | >98.00% | |
UDP-Glucosamine is a sugar nucleotide analog, glycosyl donor, and metabolite of D-galactosamine. | ||||
| GC79816 | Cryptolepine | 480-26-2 | >98.00% | |
Cryptolepine is an orally active multi-potent alkaloid with anti-cancer, anti-bacterial, anti-viral, anti-malarial, anti-inflammatory, anti-hyperglycemic, relieve pain and other properties. | ||||
| GC79866 | Gem-C12 | 849139-19-1 | >99.00% | |
Gem-C12 is a prodrug of Gemcitabine. | ||||
| GC79867 | Prexasertib-d 4 | - | >98.00% | |
Prexasertib -d 4 (LY2606368-d 4 ) is the deuterium labeled Prexasertib. | ||||
| GC79871 | CHNQD-00824 | 2222643-74-3 | >98.00% | |
CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect. | ||||
| GC79988 | GS-441524-d | 2647440-98-8 | >98.00% | |
GS-441524 -d is the deuterium labeled GS-441524. | ||||
| GC79989 | Irinotecan- 13 C 6 | 718613-65-1 | >98.00% | |
Irinotecan - 13 C 6 ((+)-Irinotecan- 13 C 6 ) is the 13 C-labeled Irinotecan. | ||||
| GC79990 | Gemcitabine- 13 C, 15 N 2 | 1233921-74-8 | >99.00% | |
antimetabolite and an antineoplastic agent. | ||||
| GC79991 | Im-m7GDP sodium | 240137-51-3 | >89.00% | |
Im-m7GDP sodium is a capping reagent and also the P-imidazolide of N7-methylguanosine 5'-diphosphate. | ||||
